Top all-time · #5984
Celine Halioua
Personal blog · celinehh.comstartupshealthcareer
Celine Halioua's personal blog at celinehh.com covers startups, health and career. Since 2020, 13 different Hacker News readers have linked it 25 times, most often “Applying tech frameworks to biotech: key differences”. No feed was found, so read it on the site itself.
Too few sampled comments (4) to say how often HN recommends it.?
Why HN links it
HN readers link Celine Halioua's blog for writing on aging research and biotech, including her essays on the aging field, her experience as a founder raising a seed round, and her criticism of Aubrey de Grey and SENS.
Summarised by Claude from a sample of 4 HN comments that link here. Each comment is marked recommending, critical or neutral (citing without judging); how this works.
Most-linked posts?
- Applying tech frameworks to biotech: key differences5 people · 8 mentions · first linked 2020-07-13
- How to Build a Biotech2 people · 2 mentions · first linked 2020-07-13
- From Academia to Startups – Common Founder Foibles2 people · 2 mentions · first linked 2021-03-29
- Allegations against Aubrey de Grey2 people · 2 mentions · first linked 2021-08-11
- What the Aging Field Needs2 people · 2 mentions · first linked 2021-05-11
What Hacker News says?
Favorite blogs about aging, biotech: - https://www.ldeming.com/longevityfaq - https://nintil.com/ - https://srconstantin.github.io/tag/aging.html - https://www.celinehh.com/
Comment linking /
on “Ask HN: Favorite Blogs by Individuals?”Submitted How I raised a $5.1M seed as a first-time, female, solo founder for a biotech co as a story · 284 points
HN discussionIf they can help dogs to live longer, which animal could be next? https://www.celinehh.com/aging-field > The reasons we do not have an approved aging drug today are not due to the science - the biological blockers to a first-generation aging drug have been clear for at least ten years. The primary reasons there are no approved aging drugs today are much more tricky - they are regulatory, societal, structural, and cu…
Comment linking /aging-field
on “How I raised a $5.1M seed as a first-time, female, solo founder for a biotech co”Submitted How to Build a Biotech as a story · 133 points
HN discussionCeline Halioua isn't "anonymous", she's a successful aging researcher and her complaints are if anything, even more damning for Aubrey and the SENS folks: https://www.celinehh.com/aubrey
Comment linking /aubrey
on “I've decided not to work with Aubrey de Grey or SENS”Submitted Allegations against Aubrey de Grey as a story · 68 points
HN discussionShe has another, rather dark, post where she concludes that she wouldn't have succeeded without being harassed by someone at university, and that she's on her own: https://www.celinehh.com/gifts-of-my-harasser
Comment linking /gifts-of-my-harasser
on “Navigating Silicon Valley as a Female Founder”Submitted Applying tech frameworks to biotech: key differences as a story · 48 points
HN discussionSubmitted From Academia to Startups – Common Founder Foibles as a story · 45 points
HN discussionSubmitted Learnings from Running a Longevity Startup as a story · 41 points
HN discussionSubmitted Navigating Silicon Valley as a Female Founder as a story · 35 points
HN discussionSubmitted Applying tech frameworks to biotech: key differences as a story · 4 points
HN discussionSubmitted Social and personal trade-offs of building a startup as a story · 3 points
HN discussionSubmitted Tech vs. Biotech as a story · 3 points
HN discussionSubmitted Applying tech frameworks to biotech: key differences as a story · 3 points
HN discussionSubmitted Ambition and SSRIs as a story · 2 points
HN discussionSubmitted Applying tech frameworks to biotech: key differences as a story · 2 points
HN discussionSubmitted Tech vs. Biotech as a story · 2 points
HN discussionSubmitted Year 4 Startup Learnings as a story · 1 points
HN discussionSubmitted How to Build a Biotech as a story · 1 points
HN discussionSubmitted Year 3 Startup Learnings as a story · 1 points
HN discussionSubmitted What the Aging Field Needs as a story · 1 points
HN discussionSubmitted From Academia to Startups – Common Founder Foibles as a story · 1 points
HN discussionSubmitted Applying tech frameworks to biotech: key differences as a story · 1 points
HN discussionSubmitted Applying tech frameworks to biotech: key differences as a story · 1 points
HN discussion
